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A B S T R A C T
Bacteremia is currently one of the infections with the highest mortality in hospitals [1]. Acinetobacter
lwofﬁi and Acinetobacter baumannii are gram-negative bacteria and both represent opportunistic
pathogens. In certain cases, the management can be challenging since these organisms can be highly
resistant to antimicrobial agents. Clinical illnesses associated with Acinetobacter include pneumonia,
meningitis, peritonitis, endocarditis and infections of the urinary tract and skin [1]. Acinetobacter
bacteremia represents a serious and ever increasing problem because of the high associated morbidity
and mortality.
 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Contents lists available at ScienceDirect
IDCases
jo u rn al ho m epag e: ww w.els evier . c om / lo cat e/ idc rIntroduction
The source of bacteremia with Acinetobacter species is
frequently unknown. In 21–70% of cases, the source remains
undetermined [2]. The crude death rate associated with Acineto-
bacter spp. bacteremia is high, usually ranging from 22% to 52% [2].
Seifert et al. reported a 19% mortality directly associated with
Acinetobacter baumannii bacteremia, and found that the indepen-
dent factors associated with a higher mortality were the presence
of a rapidly fatal underlying disease, mechanical ventilation, initial
septic shock, and pneumonia as the primary source of infection [2].
Other factors associated with mortality were the presence of DIC
and the use of inappropriate antimicrobial therapy [2]. We present
a case of disseminated intravascular coagulation (DIC) triggered by
Acinetobacter infection in an asplenic patient.
Case
A 46-year old Caucasian female with a history of intravenous
drug abuse, hypertension and traumatic splenectomy (after a
motor vehicle accident 12 years prior), presented to our institution
with altered mental status for the past one day. She was also a* Corresponding author at: 655W 8th St, Jacksonville, FL 32209, United States.
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4.0/).chronic smoker and had a history of noncompliance to vaccina-
tions. On arrival to the emergency department, she had multiple
episodes of coffee ground emesis and tarry colored stools.
On examination, she was febrile up to a temperature 101.7 F
and persistently hypotensive with blood pressure (BP) 74/22, and
heart rate 70 beats per min (bpm). A petechial rash was noted
initially on her face, but then rapidly became generalized
spreading to her arms, legs and trunk (see Figs. 1–3). She also
had multiple track marks on both upper extremities. Digital rectal
examination was guaiac positive. Gastric lavage was also signiﬁ-
cant for 800cc coffee ground ﬂuid.
Since she did not respond to aggressive intravenous ﬂuid
resuscitation, pressors had to be started. She also requiredFig. 1. Showing maculopapular rash located on patient’s arm with track marks.
e under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
Fig. 2. Showing maculopapular rash located on patient’s leg.
Fig. 3. Showing petechial rash on patient’s neck.
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metronidazole were empirically started. Chest X-ray (CXR) did
not show any evidence of cardiopulmonary disease. Head
computer tomography (CT) without contrast did not reveal any
abnormalities. Laboratory data showed a lactic acid of 8.5 and also
evidence of coagulopathy consistent with DIC. Blood cultures
revealed gram negative rods on gram stain. Despite prompt
antibiotic treatment and administration of fresh frozen plasma and
platelets, she passed away on the day of admission. Soon after her
demise, the blood cultures resulted A. baumannii and Acinetobacter
lwofﬁi. The microbiological result was conﬁrmed by molecular
methods. Both species of Acinetobacter were pansusceptible.
Family declined autopsy.
Discussion
The recent taxonomy of the genus Acinetobacter was proposed
by Bouvet and Grimont [5,7] in 1986 and expanded later [6,7] to
include the seven named genomospecies (Acinetobacter calcoace-
ticus, A. baumannii, Acinetobacter haemolyticus, Acinetobacter junii,
Acinetobacter johnsonii, A. lwofﬁi and Acinetobacter radioresistens)
and nine unnamed genomospecies [7].
It has been noted that the mortality rate from bacteraemia is
one of the highest among infections in hospitals, especially in the
intensive care [1] unit (ICU). Acinetobacter species are widely
distributed in nature and are recoverable readily from moist and
dry surfaces [5]. This organism can colonize almost any human
body site either transiently or as normal ﬂora [5]. Both A.
baumannii and A. wolfﬁi can be found as part of normal skin ﬂora
in approximately 25% of the healthy individuals [4].
Our patient was an intravenous (IV) drug user. She had multiple
track marks on her upper extremities, suggestive of active drug
use. This was likely the source of her bacteremia since other
sources were considered to be much less likely. She did not have
any gastrointestinal complaints prior to arrival to the hospital and
her last hospitalization was more than ﬁve months prior to thispresentation precluding that this could have been related to an IV
line from a previous admission.
Inherent bacterial virulence factors of Acinetobacter spp. are not
well elucidated, although it is known that the organism is
encapsulated, which may enable it to ‘‘escape’’ phagocytosis.
Our patient was asplenic, therefore this likely contributed to the
severity of her infection.
The production of an exopolysaccharide protects Acinetobacter
spp. from other innate immune mechanisms [5]. The ability of this
organism to participate in production of bioﬁlms at epithelial cell
interfaces and its innate iron acquisition systems for survival in a
host’s iron-poor environment also contribute to its pathogenicity [5].
Acinetobacter bacteremia represents a grave problem because of
its high associated morbidity and mortality and, especially, because
of the development of antimicrobial resistance. This resistance is
developing so rapidly that it can almost be seen as a harbinger of the
so-called post-antibiotic era [2]. Measures are needed to prevent and
control infections caused by Acinetobacter species and to improve
the use of antimicrobial agents to avoid, or at least delay, the
appearance of newly resistant strains. The resistance pattern of the
A. lwofﬁi isolate could be similar to other Acinetobacter species,
which produce an AmpC beta-lactamase that inactivates aminope-
nicillins and narrow-spectrum cephalosporins [8].
In the case presented above, both species of Acinetobacter were
pansusceptible, therefore antibiotic coverage was appropriate.
Likely the only factor that might have changed the outcome is if the
patient would have presented sooner to the hospital.
While A. baumannii, which is frequently associated with
outbreaks, is still by far the most common of the Acinetobacter
species among clinical isolates [3], it is clear that the lesser-known
species, such as A. lwofﬁi have been associated with serious
infections, therefore may represent emerging pathogens.
In conclusion, to our knowledge, we present the ﬁrst case of
intravenous drug use related A. lwofﬁi and baumannii bacteremia.
The poor outcome of this case was likely due to an increased
severity of infection due to asplenia and late presentation of the
patient to the hospital.
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